Gene: PQBP1
Official Full Name: polyglutamine binding protein 1provided by HGNC
Gene Summary: This gene encodes a nuclear polyglutamine-binding protein that is involved with transcription activation. The encoded protein contains a WW domain. Mutations in this gene have been found in patients with Renpenning syndrome 1 and other syndromes with X-linked cognitive disability. Multiple alternatively spliced transcript variants that encode different protein isoforms have been described for this gene.[provided by RefSeq, Nov 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06775 | PQBP1 Knockout cell line (HeLa) | Human | PQBP1 | 1:3~1:6 | Negative | Online Inquiry |
KO06776 | PQBP1 Knockout cell line (HCT 116) | Human | PQBP1 | 1:2~1:4 | Negative | Online Inquiry |
KO06777 | PQBP1 Knockout cell line (HEK293) | Human | PQBP1 | 1:3~1:6 | Negative | Online Inquiry |
KO06778 | PQBP1 Knockout cell line (A549) | Human | PQBP1 | 1:3~1:4 | Negative | Online Inquiry |
PQBP1 Gene Knockout Cell Lines are specialized cell lines genetically modified to lack the expression of the PQBP1 gene, which encodes the polyglutamine binding protein 1. These cell lines serve as vital tools for molecular biology research, particularly in the study of neurodegenerative diseases and developmental disorders where PQBP1 has been implicated. The knockout of this gene allows researchers to investigate the downstream effects of PQBP1 deficiency on cellular processes such as neuronal differentiation, synaptic function, and RNA splicing.
Functionally, the PQBP1 gene knockout alters critical signaling pathways and may lead to phenotype changes in developmental biology. This enables scientists to better understand the functional implications of PQBP1 loss and its roles in pathophysiological conditions. Characterization of these cell lines can reveal subcellular changes, alterations in gene expression profiles, and the mechanisms contributing to disease progression, thereby providing insights that could inform therapeutic approaches.
Scientifically, PQBP1 Gene Knockout Cell Lines have extensive applications in both research and clinical settings. They serve as effective models for drug testing, genetic analysis, and exploring potential gene therapies, particularly in conditions linked to aberrant PQBP1 function. Their relevance is underscored by emerging studies that pinpoint PQBP1’s involvement in several neurodevelopmental disorders, making these cell lines crucial for targeted investigations.
Compared to traditional models, the PQBP1 knockout lines offer distinct advantages, including a more tailored approach to studying PQBP1-related pathology, the elimination of confounding genetic variables, and improved reproducibility of experimental results. By utilizing these cell lines, researchers can streamline their experimental designs, saving valuable time and resources.
For researchers, clinicians, and other stakeholders in the life sciences, PQBP1 Gene Knockout Cell Lines present an invaluable asset for advanced studies into genetic expressions and disease mechanisms. Our company is committed to providing high-quality biological products backed by rigorous scientific standards and extensive expertise, ensuring users have the best tools for their research needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.